GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Other Gross PPE

JFL Life Sciences (NSE:JFLLIFE) Other Gross PPE : ₹0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences Other Gross PPE?

JFL Life Sciences's Other Gross PPE for the quarter that ended in Mar. 2024 was ₹0.0 Mil.

JFL Life Sciences's quarterly Other Gross PPE declined from Mar. 2022 (₹0.0 Mil) to Mar. 2023 (₹0.0 Mil) but then stayed the same from Mar. 2023 (₹0.0 Mil) to Mar. 2024 (₹0.0 Mil).

JFL Life Sciences's annual Other Gross PPE declined from Mar. 2022 (₹0.0 Mil) to Mar. 2023 (₹0.0 Mil) but then stayed the same from Mar. 2023 (₹0.0 Mil) to Mar. 2024 (₹0.0 Mil).


JFL Life Sciences Other Gross PPE Historical Data

The historical data trend for JFL Life Sciences's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences Other Gross PPE Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Gross PPE
Get a 7-Day Free Trial - - - - -

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Gross PPE Get a 7-Day Free Trial - - - - -

JFL Life Sciences Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


JFL Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines